Trial Profile
A Phase III, Observer-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix (GlaxoSmithKline Biologicals) Compared With Fluzone (Aventis Pasteur) Administered Intramuscularly in Adults 18 Years and Older in the U.S.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline; GSK
- 23 Oct 2010 New trial record